Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) Return on equity

Alert me on Return on equity

Chemed Corporation's return on equity over the twelve months to 30 September 2026 was 29.1%, up 3.9 percentage points from fiscal 2025 (25.3%). Over the past ten years it has ranged from 18.5% (fiscal 2017) to 39.3% (fiscal 2020); the current reading is higher than 36% of that period. That is above the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.

Return on equity, annual

Embed this chart

Annual newest first

Period Return on equity Change (points)
FY2025 25.3% (1.84)
FY2024 27.1% (1.47)
FY2023 28.6% (6.52)
FY2022 35.1% (0.12)
FY2021 35.2% (4.02)
FY2020 39.3% 5.88
FY2019 33.4% (2.96)
FY2018 36.3% 17.88
FY2017 18.5% (2.52)
FY2016 21.0% (1.89)

Against its own ten years

Low 18.5% High 39.3%
Ten-year median 28.6%
Current reading's percentile 36

Return on equity against peers

What Return on equity is

ROE shows how much profit a company earns for its shareholders on the equity they have in the business.

Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)

The full definition of Return on equity →

More on CHE